image
Healthcare - Biotechnology - NASDAQ - US
$ 8.73
0.345 %
$ 4.51 M
Market Cap
-0.01
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
--40.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets CERo Therapeutics Holdings, Inc.
image
CERO has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart CERO

image
$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CERO

image
$0.0$0.0($1.0m)($1.0m)($2.0m)($2.0m)($3.0m)($3.0m)($4.0m)($4.0m)($5.0m)($5.0m)($6.0m)($6.0m)($7.0m)($7.0m)($8.0m)($8.0m)202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CERO

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)202420242025202520262026202720272028202820292029